HEGGIE THERESA
SEC CIK 1760020 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| BCRX | BIOCRYST PHARMACEUTICALS INC | Dir | 80.6K | — | $1.14M | 22 | 2021-08-31 | 2026-06-11 |
Most active insiders at BCRX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Barnes Alane P | CLO | — | $3.46M |
| 2 | HEGGIE THERESA | Dir | — | $504.8K |
| 3 | McKee Amy E | Dir | — | $100.3K |
| 4 | SANDERS MACHELLE | Dir | — | $68.5K |
| 5 | Menon Sandeep | Chief R, D Off | — | — |
| 6 | Ghias Babar | CFO | — | — |
| 7 | Gayer Charles K | Pres, CCO | — | — |
| 8 | Milne Jill C. | Dir | — | — |
| 9 | Frank Steven | Dir | — | — |
| 10 | Galson Steven K | Dir | — | — |
Transactions 22
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-15 16:06 | 2026-06-11 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | A - Grant | $0.00 | +15.3K | 80.6K | +23% | $0 |
| D | 2026-03-24 | 2026-03-20 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | M - OptEx | $6.30 | +49.9K | 115.3K | +76% | +$314.6K |
| D | 2026-03-24 | 2026-03-20 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | S - Sale+OE | $10.11 | -49.9K | 65.4K | -43% | -$504.8K |
| D | 2025-08-15 | 2025-08-13 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | S - Sale+OE | $8.51 | -70.0K | 65.4K | -52% | -$595.7K |
| DM | 2025-08-15 | 2025-08-13 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | M - OptEx | $4.34 | +70.0K | 95.4K | +276% | +$303.7K |
| D | 2025-06-16 | 2025-06-12 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | A - Grant | $0.00 | +12.5K | 65.4K | +24% | $0 |
| D | 2024-06-14 | 2024-06-12 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | A - Grant | $0.00 | +6,820 | 59.5K | +13% | $0 |
| D | 2024-06-14 | 2024-06-14 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | S - Sale | $6.11 | -6,698 | 52.9K | -11% | -$40.9K |
| 2024-06-03 | 2024-05-31 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | A - Grant | $6.46 | +870 | 52.7K | +2% | +$5,620 | |
| 2024-03-04 | 2024-02-29 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | A - Grant | $5.63 | +999 | 51.9K | +2% | +$5,624 | |
| 2023-12-01 | 2023-11-30 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | A - Grant | $5.88 | +956 | 50.9K | +2% | +$5,621 | |
| 2023-09-05 | 2023-08-31 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | A - Grant | $7.11 | +791 | 49.9K | +2% | +$5,624 | |
| D | 2023-06-15 | 2023-06-13 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | A - Grant | $0.00 | +16.7K | 49.1K | +52% | $0 |
| 2023-06-02 | 2023-05-31 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | A - Grant | $8.27 | +680 | 32.4K | +2% | +$5,624 | |
| 2023-03-02 | 2023-02-28 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | A - Grant | $8.85 | +635 | 31.7K | +2% | +$5,620 | |
| 2022-12-02 | 2022-11-30 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | A - Grant | $13.36 | +421 | 31.1K | +1% | +$5,625 | |
| 2022-09-02 | 2022-08-31 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | A - Grant | $13.90 | +404 | 30.6K | +1% | +$5,616 | |
| D | 2022-06-09 | 2022-06-07 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | A - Grant | $0.00 | +12.9K | 30.2K | +74% | $0 |
| 2022-06-02 | 2022-05-31 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | A - Grant | $9.31 | +1,138 | 17.4K | +7% | +$10.6K | |
| 2022-03-02 | 2022-02-28 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | A - Grant | $16.61 | +602 | 16.2K | +4% | +$9,999 | |
| 2021-12-02 | 2021-11-30 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | A - Grant | $12.06 | +829 | 15.6K | +6% | +$9,998 | |
| 2021-09-02 | 2021-08-31 | BCRX | BIOCRYST PHARMACEUTICALS INC | HEGGIE THERESA | Dir | A - Grant | $15.92 | +628 | 14.8K | +4% | +$9,998 |
Purchase Sale Sale after option exercise All abbreviations